ATMA Capital’s Post

Munich-based startup Orbem is leveraging AI and industrial MRI scanning technology to rapidly determine the gender of eggs in a non-invasive manner, replacing traditional slow methods. This innovation, initially targeted at the poultry industry to address issues related to gender determination and waste, has garnered significant attention and funding, with Orbem recently securing a €30 million ($31.8 million) Series A funding round led by 83North. The company's technology has the potential to be applied to various sectors, including agriculture, construction, and even medical imaging in humans, highlighting the growing trend of AI and MRI integration. You may delve into further detail in the article provided at https://lnkd.in/eTyHch8F #technology #AI #innovation #industry

Discover the future of Biotechnology and AI! 💡 Aswin AK unveils the Top 15 Innovations set to redefine healthcare, agriculture, and more in 2024. Revolutionary advancements are on the horizon - from AI in drug discovery to personalized medicine and sustainable agriculture. Curious? Dive into the full article here https://lnkd.in/g3U8AGrG. Let's discuss the future! #Biotechnology #ArtificialIntelligence #Innovation #FutureTrends

Rapid advancements in AI tools are driving the design of diverse antibodies and proteins. The thoughtful combination of AI-based predictive tools and experimental approaches can potentially enable broad biotech patent genus claims. Ken Seidenman explains in his thought-provoking article, 'Biotech Patents in an AI-Enabled World'. 👉 Read the full article and follow our Beyond Human Ingenuity Series for more insights into AI's role in modern invention: https://shorturl.at/0dfy0 #AIinIP #IntellectualProperty #IP #Innovation #PatentLaw #AI #biotechpatents #biotech #BeyondHumanIngenuity

Fast-tracking innovation in protein engineering with AI 🔬 By applying AI to protein design, startups are leveraging technology to predict and optimise protein sequences. With powerful prediction algorithms they can meet specified protein design goals. This enables faster protein design and reduces both the cost and time of getting a SynBio product to market. Who have we missed? And who should I chat with on the topic? Adaptyv Bio Cambrium Cradle Exazyme Officinae Bio Opera Bioscience Ready to hear more? We'll tell all in our FoodHack Trend Report. Throwback to debating where are we on offering SynBio as a service at the HackSummit 📸

The advent of AI in synbio is a big deal. I am happy to share my interview with Miriam Fernandez, CFA, Director, AI research specialist at S&P Global, where she shares strategic aspects and future vision of the field. Miriam recently authored an insightful report "Artificial Intelligence Powering Synthetic Biology: The Fundamentals," (link in the comments) and here are some high-level takeaways: ✔ The convergence of AI and synthetic biology is set to transform sectors such as healthcare, agriculture, renewable energy, and environmental remediation. By combining AI's data-processing prowess with Synbio's genetic manipulation capabilities, we could achive better scalability, cost reduction and unlock further innovation. ✔ From ancient agricultural practices to modern technologies like CRISPR, genetic manipulation has evolved dramatically. The plummeting costs of DNA sequencing have accelerated this progress, enabling more extensive and precise genetic modifications. ✔ While AI can streamline genetic modification processes and reduce costs, the integration of these technologies also presents ecological, biosecurity, and ethical challenges that must be carefully managed. ✔ Effective collaboration among biology, engineering, and technology disciplines is crucial. New tools, including generative AI, enhance communication and cooperation, driving innovation in Synbio. ✔ Balancing innovation with safety and ethical considerations is vital. Different regulatory approaches, such as the EU's human-centric risk-based model and the US's sector-based strategy, aim to manage risks while fostering innovation. ✔ Public acceptance and understanding will play a significant role in the development and implementation of AI and Synbio. Transparent communication and education are essential for societal engagement. ✔ AI and Synbio have the potential to address critical issues like climate change and food security. Innovations in waste-to-energy transformations, CO2 conversion, and sustainable agriculture are just a few examples. ✔ The scalability of Synbio powered by AI promises transformative innovations, making processes more efficient and cost-effective. However, we must anticipate and mitigate potential ecosystem imbalances and biosecurity risks. Read the full interview on BioPharmaTrend.com (link in the comments). Subscriber to Where Tech Meets Bio (Substack Newsletter) to recieve weekly recaps of tech+bio news, and analysis of the tech market. #biopharmatrend #synbio #artificialintelligence #genAI #bioeconomy Image credit: S&P GlobaL

AI presents an incredible opportunity for accelerating innovation! In my latest article, 'Biotech Patents in an AI-Enabled World', I delve into how AI tools are transforming the design of diverse antibodies and proteins. This blend of technology and science is reshaping what’s possible in biotech. Broader biotech patent genus claims will likely be obtainable by integrating AI-based predictive tools with experimental approaches. 👉 Read the full article and join the conversation in our Beyond Human Ingenuity Series to gain more insights into AI’s transformative role in modern invention: https://shorturl.at/HwQGJ #AIinIP #IntellectualProperty #IP #Innovation #PatentLaw #AI #biotechpatents #biotech #BeyondHumanIngenuity FB Rice

Today's #interestingread is all about how #AI works under the hood. The authors looked into one specific type of AI - graph neural networks - and how these #machinelearning models are able to predict protein-ligand interactions. Their question was, do these models actually 𝙡𝙚𝙖𝙧𝙣 details of protein–ligand interactions? Or is something else going on? Read the whole article to get a glimpse into the "black box" 👉https://lnkd.in/es2XTktj Speaking of AI... Did you know that Kevin Leempoel, Senior #Bioinformatics Scientist & Team Lead #DataScience at BioLizard, will share his expertise on marking smart use of #artificialintelligence in #plantbiotech 𝗧𝗢𝗠𝗢𝗥𝗥𝗢𝗪? 𝗠𝗼𝗿𝗲 𝗶𝗻𝗳𝗼 & 𝗲𝘃𝗲𝗻𝘁 𝗿𝗲𝗴𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻 𝗵𝗲𝗿𝗲 👉https://lnkd.in/eM6DDhDh #neuralnetworks #ML #AIforHealth #drugdiscovery #biotech

Can't wait for next week's #DigitalScience & #Innovation Day in Leiden 🚀 Learn from thought leaders, covering topics such as the latest trends, challenges, and success stories in modernising R&D and join your industry peers on one of the two following intimate roundtable discussions:    1) Reimagining #Collaboration: Building effective strategies to accelerate time to market 👉 Discuss how modern #biotechnology companies are using connected software to evolve their R&D approach and improve collaboration to produce more efficiently. 2) #AI in biotech: Doing better, not just faster, with AI 👉 Target identification and molecule design have seen the lion’s share of AI and ML focus in biotech. But more opportunity awaits for labs that bring these tools downstream. Join us to discuss how scientists are applying AI to process development, parameter optimization, IND filings, and more. A few seats are left, get your free ticket here: https://lnkd.in/eu5-4jmD Together with Benchling, Kadans Science Partner and Clustermarket #labops #digitallab #labautomation Science Entrepreneur Club

🚀 A Review of PentaBind’s New Service: SELEX Analysis! 🚀 PentaBind's advanced AI technology provides a definitive analysis of your SELEX experiments, ensuring no high-performance aptamers are overlooked. What We Offer: Our SELEX Analysis service is specifically designed for organisations with aptamer SELEX data. This service uses AI to confirm the success of your SELEX experiment by analysing the data you submit, identifying SELEX enrichment and SELEX biased sequences. 🧬🔍 Key Features: - Accurate identification of SELEX enrichment 💡 - Detection of SELEX biased sequences 🎯 - Comprehensive analysis of SELEX data 📈 Traditional bioinformatics using frequency/abundance analysis might be missing high-performance aptamers in your SELEX data. PentaBind's SELEX Analysis ensures that you uncover the best-performing sequences. We offer a free trial service to get you started, and the paid version provides detailed insights into the top-performing, unique sequences. View Demo Report and Arrange a call with us to learn more https://lnkd.in/d5m4C7TF Discover how our SELEX Analysis service can optimise your research and reveal the full potential of your SELEX experiments. Embrace the future of aptamer technology with PentaBind.com #SELEXAnalysis #AI #Biotechnology #Research #Innovation #PentaBind #AptamerTechnology #tech #techbio #ai #startups #drugdiscovery #aptamers #oligos #generativeai #biotech #community #pharma #artificialintelligence #venturecapital

🎉 Exciting News from PentaBind! 🎉 We are pleased to announce PentaBind's four new AI-powered aptamer services, offering unprecedented solutions for the aptamer industry 🚀: 🩺 Aptamer Evaluation: Use AI to quickly evaluate the performance of an existing aptamer e.g. from a catalogue or from an academic paper. Receive detailed performance evaluations within <48 hours, including insights on binding affinity, specificity, SELEX bias, and more. ✨ Aptamer Design: Generate de novo aptamers with PentaBind's AI and wet-laboratory platform. PentaBind understands that aptamer commercialisation projects need aptamers with more characteristics than binding affinity alone. This is why we built our platform to design high-performing aptamers with enhanced binding, specificity, conformational folding, and more. Services specifically for organisations with aptamer SELEX data: 🔍 SELEX Analysis: Use AI to definitively confirm if your SELEX experiment had successful enrichment and which sequences performed best. Traditional bioinformatics using frequency/abundance analysis might be missing high-performance aptamers in your SELEX data. 🧬 Optimised SELEX Libraries: Receive AI-optimised, customised aptamer libraries to use within your SELEX experiment to significantly reduce search space and boost your SELEX efficiency, discovering up to 300 times more candidates. 🤝 Share this post with anyone you think may find these services valuable! Discover how PentaBind can revolutionise your research: https://lnkd.in/d5m4C7TF Schedule a call with PentaBind to learn more: https://lnkd.in/d2JggX36 #AptamerDesign #Biotechnology #AI #ResearchInnovation #PentaBind #tech #techbio #startups #drugdiscovery #aptamers #oligos #antibody #antibodies #generativeai #biotech #community #pharma #artificialintelligence #venturecapital